MARATTO

article · Journal of Biomolecular Structure and Dynamics

Exploring natural products as multi-target-directed drugs for Parkinson’s disease: an <i>in-silico</i> approach integrating QSAR, pharmacophore modeling, and molecular dynamics simulations

Abstract

R exhibited higher stability with CNP0242698 compared to the reference complex, despite the high initial ligand RMSD due to the bulkier active site. In NMDAR, CNP0242698 displayed good stability and less fluctuations implying a more restricted conformation within the smaller active site of NMDAR. These results may serve as lead compounds for the development and optimization of natural products as multi-target disease-modifying natural remedies for Parkinson's disease patients. However, experimental assays remain necessary to validate these findings.Communicated by Ramaswamy H. Sarma.

Research topics

  • Computational Drug Discovery Methods
  • Multicomponent Synthesis of Heterocycles
  • Cholinesterase and Neurodegenerative Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/07391102.2023.2260879

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.